CONVENTIONAL CHEMOIMMUNOTHERAPY (R-CHOEP-14) OR HIGH-DOSE THERAPY (R-MEGA-CHOEP) FOR YOUNG, HIGH-RISK PATIENTS WITH AGGRESSIVE B-CELL LYMPHOMA: FINAL RESULTS OF THE RANDOMIZED MEGA-CHOEP-TRIAL OF THE GERMAN HIGH-GRADE NON-HODGKIN LYMPHOMA STUDY GROUP (DSHNHL)
2011 | conference abstract. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
CONVENTIONAL CHEMOIMMUNOTHERAPY (R-CHOEP-14) OR HIGH-DOSE THERAPY (R-MEGA-CHOEP) FOR YOUNG, HIGH-RISK PATIENTS WITH AGGRESSIVE B-CELL LYMPHOMA: FINAL RESULTS OF THE RANDOMIZED MEGA-CHOEP-TRIAL OF THE GERMAN HIGH-GRADE NON-HODGKIN LYMPHOMA STUDY GROUP (DSHNHL)
Schmitz, N.; Nickelsen, M.; Ziepert, M.; Borchmann, P.; Nickenig, C.; Viardot, A. & Bentz, M. et al. (2011)
Annals of Oncology, 22 pp. 106-107. 11th International Conference on Malignant Lymphoma, Lugano, SWITZERLAND.
Oxford: Oxford Univ Press.
Documents & Media
Details
- Authors
- Schmitz, Norbert; Nickelsen, M.; Ziepert, Marita; Borchmann, Peter; Nickenig, C.; Viardot, Andreas; Bentz, Martin; Truemper, Lorenz H.; Loeffler, Markus; Pfreundschuh, Michael; Glass, Bertram
- Issue Date
- 2011
- Status
- published
- Publisher
- Oxford Univ Press
- Journal
- Annals of Oncology
- Conference
- 11th International Conference on Malignant Lymphoma
- Conference Place
- Lugano, SWITZERLAND
- ISSN
- 1569-8041; 0923-7534
